Association between ABCB1-T1236C polymorphism and drug- resistant epilepsy in Iranian female patients

Iranian Biomedical Journal

Volumn 14, Issue 3, 2010, Pages 89-96

  Maleki, Mehri ^a,b   Sayyah, Mohammad ^a   Kamgarpour, Fatemeh ^a,c   Karimipoor, Morteza ^a   Arab, Aida ^a   Rajabi, Anahita ^a   Gharagozli, Kourosh ^d   Shamshiri, Ahmad Reza ^e   Ananloo, Esmaeil Shahsavand ^f  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c Khatam University   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ATP binding cassette subfamily B member 1 (ABCB1); Drug resistant epilepsy; Single nucleotide polymorphism

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; ETIRACETAM; LAMOTRIGINE; MULTIDRUG RESISTANCE PROTEIN 1; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TOPIRAMATE; VALPROIC ACID;

ADULT; ARTICLE; CHILD; COMPLEX PARTIAL SEIZURE; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG RESPONSE; EPILEPSY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MYOCLONUS EPILEPSY; PHENOTYPE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TONIC CLONIC SEIZURE;

ADULT; AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; DEMOGRAPHY; DRUG RESISTANCE; EPILEPSY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IRAN; MALE; ODDS RATIO; P-GLYCOPROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 78649564067     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Porter, R.J. and Meldrum, B.S. (2001) Antiseizure drugs. In: Basic and Clinical Pharmacology. (Katzung, B.G., ed.), McGraw- Hill, New York, USA. pp. 395.
2. Kwan, P. and Brodie, M.J. (2000) Early identification of refractory epilepsy. N. Engl. J. Med. 342: 314-319.
3. Sisodiya, S.M. (2003) Mechanisms of antiepileptic drug resistance. Curr. Opin. Neurol. 16: 197-201.
4. Loscher, W. and Potschka, H. (2005) Drug resistance in brain diseases and the role of drug efflux transporters. Nat. Rev. Neurosci. 6: 591-602.
5. Potschka, H., Fedrowitz, M., and Loscher, W. (2001) P-glycoprotein and multidrug resistance-associated protein are involved in the regulation of extracellular levels of the major antiepileptic drug carbamazepine in the brain. Neuroreport 12: 3557-3560.
6. Potschka, H. and Loscher, W. (2001) In vivo evidence for P-glycoprotein-mediated transport of phenytoin at the blood-brain barrier of rats. Epilepsia 42: 1231-1240.
7. Loscher, W. and Potschka, H. (2002) Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J. Pharmacol. Exp. Ther. 301: 7-14.
8. Loscher, W. and Delanty, N. (2009) MDR1/ABCB1 polymorphisms and multidrug resistance in epilepsy: in and out of fashion. Pharmacogenomics 10: 711-713.
9. Zimprich, F., Sunder-Plassmann, R., Stogmann, E., Gleiss, A., Dal-Bianco, A., Zimprich, A., Plumer, S., Baumgartner, C. and Mannhalter, C. (2004) Association of an ABCB1 gene haplotype with pharmacoresistance in temporal lobe epilepsy. Neurology 63: 1087-1089.
10. Hung, C.C., Tai, J.J., Lin, C.J., Lee, M.J. and Liou, H.H. (2005) Complex haplotypic effects of the ABCB1 gene on epilepsy treatment response. Pharmacogenomics 6: 411-417.
11. Seo, T., Ishitsu, T., Ueda, N., Nakada, N., Yurube, K., Ueda, K. and Nakagawa, K. (2006) ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients. Pharmacogenomics 7: 551-561.
12. Kim, Y.O., Kim, M.K., Woo, Y.J., Lee, M.C., Kim, J.H., Park, K.W., Kim, E.Y., Roh, Y.I. and Kim, C.J. (2006) Single nucleotide polymorphisms in the multidrug resistance 1 gene in Korean epileptics. Seizure 15: 67-72.
13. Kwan, P., Baum, L., Wong, V., Ng, P.W., Lui, C.H., Sin, N.C., Hui, A.C., Yu, E. and Wong, L.K. (2007) Association between ABCB1 C3435T polymorphism and drug-resistant epilepsy in Han Chinese. Epilepsy Behav. 11:112-117.
14. Lakhan, R., Misra, U.K., Kalita, J., Pradhan, S., Gogtay, N.J., Singh, M.K. and Mittal, B. (2009) No association of ABCB1 polymorphisms with drugrefractory epilepsy in a north Indian population. Epilepsy Behav. 14: 78-82.
15. Kim, D.W., Lee, S.K., Chu, K., Jang, I.J., Yu, K.S., Cho, J.Y. and Kim, S.J. (2009) Lack of association between ABCB1, ABCG2, and ABCC2 genetic polymorphisms and multidrug resistance in partial epilepsy. Epilepsy Res. 84: 86-90.
16. Regesta, G., Tanganelli, P. (1999) Clinical aspects and biological bases of drug-resistance epilepsies. Epilepsy Res. 34: 109-122.
17. Kwan, P., Brodie, M.J. (2002) Refractory epilepsy: a progressive, intractable but preventable condition? Seizure 11: 77-84.
18. Loscher, W. (2005) How to explain multidrug resistance in epilepsy? Epilepsy Curr. 5: 107-112.
19. French, J.A. (2007) Refractory epilepsy: clinical overview. Epilepsia 48 (Suppl. 1): 3-7.
20. Loscher, W., Klotz, U., Zimprich, F., Schmidt, D. (2009) The clinical impact of pharmacogenetics on the treatment of epilepsy. Epilepsia 50: 1-23.
21. Miller, S.A., Dykes, D.D. and Polesky, H.F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215.
22. Cucullo, L., Hossain, M., Rapp., E, Manders, T., Marchi, N. and Janigro, D. (2007) Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs. Epilepsia 48: 505-516.
23. Luna-Tortos, C., Fedrowitz, M. and Loscher, W. (2008) Several major antiepileptic drugs are substrates for human P-glycoprotein. Neuropharmacology 55: 1364-1375.